Physician profile
Karim Mahmoud
NPI 1346716412
$30,084.49
in general payments reported to CMS, 2019-2025
19 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2021: $17K · 2022: $432 · 2023: $335 · 2024: $569 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,263.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $27,576.55 | 2019-2024 | Arthrex |
| Stryker Corporation | $1,380.24 | 2019-2025 | Infinity, Inbone |
| Exactech, INC. | $196.49 | 2021 | |
| Smith+Nephew, INC. | $182.03 | 2024 | Evos, Evos Mini, Spatial Frame |
| Treace Medical Concepts, INC. | $156.85 | 2024-2025 | |
| Pacira Therapeutics, INC. | $125.02 | 2021 | |
| Bioventus LLC | $80.64 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $54.89 | 2023-2024 | Puraply |
| Innovation Technologies INC | $50.22 | 2025 | Irrisept |
| Ortho Solutions INC | $44.84 | 2024 | |
| Davol INC. | $44.38 | 2024 | Arista Ah Flexitip |
| Ultragenyx Pharmaceutical INC. | $39.99 | 2023 | |
| Anika Therapeutics, INC. | $34.64 | 2023 | Tactoset, Sportsmed Portfolio, Toe Motion |
| Paragon 28, INC. | $24.82 | 2019 | |
| Convatec INC. | $24.34 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $20.53 | 2024 | Prevena Restor Arthroform, Activ.A.C. |
| Wright Medical Technology, INC. | $18.58 | 2019 | |
| Medtronic, INC. | $16.10 | 2024 | Accurian |
| Novastep INC. | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karim Mahmoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.